Literature DB >> 1853561

Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.

G Gerken1, D Kremsdorf, F Capel, M A Petit, C Dauguet, M P Manns, K H Meyer zum Büschenfelde, C Brechot.   

Abstract

We have found a defective form of HBV2 in a HBsAg- and anti-HBe-positive patient with liver cancer. Viral deletions were identified in the preS coding region using PCR. The presence of deleted HBV forms was observed in serum, PBMC, and liver samples. After sequencing 12 clones were analyzed (subtype adr). In 9 out of 12 clones a 183-bp in-frame deletion was recorded in the preS1 region (2995 to 3177). Three out of 9 clones also yielded rearrangements of the preS2 N-terminal part. Four out of 9 showed numerous point mutations in the preS1 and preS2 sequence. In addition, 3 out of 12 clones, which did not show the 183-bp preS1 deletion were found to have small deletions and insertions in the same part of the preS1 gene. Immunological mapping using monoclonal anti-preS antibodies showed loss of preS epitopes located at the 3'-part of preS1 and the 5'-part of preS2. On the other hand, epitopes mapped to the 5'-part of preS1 and 3' of preS2 were conserved. PBMC were also tested and solely PCR showed the major form of defective HBV with preS1 183-bp deletion. However, viral deletions in the preS gene eliminated the preS2 promotor region and B- and T-cell recognition sites. In contrast to this, the preS1 binding site to hepatocytes was conserved. Therefore, such deletions would potentially lead to an impairment in viral clearance without affecting viral penetration in liver cells, possibly accounting for chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853561     DOI: 10.1016/0042-6822(91)90984-j

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

Review 1.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA.

Authors:  M Seifer; W H Gerlich
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 3.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

4.  Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum.

Authors:  Z Xu; G Jensen; T S Yen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy.

Authors:  Se Eun Kim; Yeong Hong Park; Woo Yeong Chung
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

6.  The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA.

Authors:  A H Kidd; K Kidd-Ljunggren
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

8.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

Review 9.  Polymerase chain reaction for the diagnosis of viral hepatitis B and C.

Authors:  C Bréchot
Journal:  Gut       Date:  1993       Impact factor: 23.059

10.  Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape.

Authors:  Susanne Beckebaum; Vito R Cicinnati; Xia Zhang; Stanislav Ferencik; Andrea Frilling; Hans Grosse-Wilde; Christoph Erich Broelsch; Guido Gerken
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.